flow trial semaglutide kidney outcomes results 2024 LANDMARK ALERT 🚨 REPRIEVE Trial results: Pitavastatin provides over 35% reduction in MACE in patients with HIV! Long-term kidney outcomes of semaglutide

Description

Missing injectable doses once per week is much harder than missing daily oral doses

The dosage should be determined and adjusted by a healthcare provider based on the patients response to treatment and individual needs

Diabetes education Access to experienced and caring patient educators, plus diabetes management classes, patient handouts and web resources Eating healthy support Registered dieticians who teach patients how to identify and make healthy food choices Through our holistic approach, we help patients navigate the complexities of GLP-1 therapy, ensuring they achieve the best possible outcomes while minimizing potential side effects

Contact your healthcare provider if you experience: Hot flashes accompanied by chest pain, palpitations, or irregular heartbeat Severe or persistent flushing with associated shortness of breath or dizziness Hot flashes that significantly interfere with daily activities or sleep quality New or worsening symptoms despite lifestyle modifications Severe, persistent abdominal pain (especially radiating to the back) with or without vomiting Yellowing of skin/eyes (jaundice), pale stools, or dark urine Signs of allergic reaction including facial/lip swelling, rash, hives, or difficulty breathing Signs of thyroid dysfunction including tremor, anxiety, or changes in bowel habits Concurrent symptoms such as excessive sweating, fever, or night sweats If you're taking tirzepatide with insulin or sulfonylureas, check your blood glucose during episodes that resemble hot flashes, as hypoglycemia can cause similar symptoms

References to trademarks are used solely for identification purposes and do not imply any affiliation, authorization, endorsement, sponsorship, or partnership with the respective trademark owners unless expressly stated